2, 18 Dec
Future studies should expand the sample size, comprehensively collect clinical indicators, identify pathogenic variants, and apply the Mendelian randomization (MR) method to predict causal relationships, with experimental verification as the final step
Wegovy was also approved by the FDA in 2022 for obesity and overweight
GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy, Rybelsus) have significantly improved the management of obesity and type 2 diabetes, providing effective weight loss and cardiometabolic benefits
Monitoring protocol A structured approach to heart rate monitoring provides early warning if effects are trending toward concerning territory: Baseline measurement: Before starting retatrutide, measure resting heart rate for 5 consecutive mornings immediately upon waking (before getting out of bed, before coffee, before checking your phone)